subscribeSubscribe
Tubulis Receives FDA Fast Track for TUB-040 in Ovarian Cancer

Tubulis Receives FDA Fast Track for TUB-040 in Ovarian Cancer
BUSINESSWIRE
27 Jun 2024
Share Share
Aravive Receives Third Development Milestone from 3D Medicines

Aravive Receives Third Development Milestone from 3D Medicines
GLOBENEWSWIRE
10 Oct 2022
Share Share
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination
GLOBENEWSWIRE
20 Sep 2022
Share Share
Motto International Corp. Issues Voluntary Recall of Bull Platinum

Motto International Corp. Issues Voluntary Recall of Bull Platinum
FDA
19 Dec 2019
Share Share
Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA®

Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA®
BIOSPACE
19 Oct 2019
Share Share
AstraZeneca’s Imfinzi tees up lung cancer fight with Roche

AstraZeneca’s Imfinzi tees up lung cancer fight with Roche
Angus Liu FIERCE PHARMA
28 Jun 2019
Share Share
ImmunoGen cuts deep to eke out cash for mirvetuximab trial

ImmunoGen cuts deep to eke out cash for mirvetuximab trial
Nick Paul FIERCE BIOTECH
27 Jun 2019
Share Share
Merck`s Keytruda gives BMS` Opdivo some company with small cell lung cancer nod

Merck`s Keytruda gives BMS` Opdivo some company with small cell lung cancer nod
Angus Liu FIERCE PHARMA
19 Jun 2019
Share Share
MET inhibitors from Incyte/Novartis and Germany`s Merck face off

MET inhibitors from Incyte/Novartis and Germany`s Merck face off
Natalie Grover ENDPTS
05 Jun 2019
Share Share
Shrinking 60% of lung cancers, Blueprint`s RET drug poised for 2020 filing

Shrinking 60% of lung cancers, Blueprint`s RET drug poised for 2020 filing
Amirah Al Idrus FIERCE BIOTECH
04 Jun 2019
Share Share